Department of Pediatric Cardiology, Saarland University Medical Center, Homburg 66421, Germany.
Department for Radiology, Martin-Luther-University Halle-Wittenberg, Halle 06120, Germany.
Cardiovasc Ther. 2022 Jul 18;2022:1022729. doi: 10.1155/2022/1022729. eCollection 2022.
In the postnatal period, extensive peripheral arteriovenous malformations (AVM) are associated with high morbidity, especially when localized in the liver. Their urgent treatment is always a challenging problem in neonates and infants. We analyzed four consecutive children aged three days to three years who underwent eight liquid embolization procedures with ethylene-vinyl alcohol copolymer. The AVM were situated on the thoracic wall, in the liver, and on the lower leg. In three cases, the malformations showed total regression. The tibial AVM degenerated widely. If impaired beforehand, cardiac or hepatic function normalized after the interventions. There were no embolization-associated complications such as nontarget embolization or tissue ischemia. We conclude that application of ethylene-vinyl alcohol copolymer seems to be a safe therapeutic option and can be used in neonates and infants with peripheral AVM in consideration of the agent's characteristics. Nevertheless, there are still hardly any data concerning young children.
在新生儿期,广泛的外周动静脉畸形(AVM)与高发病率相关,特别是当它们位于肝脏时。对于新生儿和婴儿来说,其紧急治疗一直是一个具有挑战性的问题。我们分析了连续的 4 名年龄在 3 天至 3 岁之间的儿童,他们接受了 8 次使用乙烯-乙烯醇共聚物的液体栓塞治疗。AVM 位于胸壁、肝脏和小腿上。在 3 例中,畸形完全消退。胫骨 AVM 广泛退化。如果之前受损,心脏或肝功能在干预后恢复正常。没有与栓塞相关的并发症,如非目标栓塞或组织缺血。我们得出结论,考虑到该药物的特性,应用乙烯-乙烯醇共聚物似乎是一种安全的治疗选择,可用于患有外周 AVM 的新生儿和婴儿。然而,关于幼儿的数据仍然很少。